• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Alex Wyke

Marketing

ViiV, Gilead and Janssen notch top scores with HIV/AIDS groups

Only half of the 168 HIV/AIDS patient groups polled in a new survey rated pharma's overall reputation "excellent" or "good."
Natalie Missakian Jun 22, 2022 9:35am

GSK's ViiV, Pfizer and Roche score high with patient groups

Apr 27, 2022 3:24am

Roche, Takeda, Pfizer rank highest with rare disease patients

Oct 4, 2021 9:15am

Roche, Pfizer, Novartis earn top 2020 marks from cancer patients

Jun 7, 2021 3:45am

U.S. patient groups might just be warming up to pharma

May 14, 2018 9:30am

Pharma's rep with patient groups drops again

Mar 21, 2017 9:53am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy